Evidence map›Paper›PMID 28242024›Full record

ArticleCellular immunology2017

Enhancement of macrophage inflammatory responses by CCL2 is correlated with increased miR-9 expression and downregulation of the ERK1/2 phosphatase Dusp6.

William F Carson, Sarah E Salter-Green, Melissa M Scola, Amrita Joshi, Katherine A Gallagher, Steven L Kunkel

Open access · greenAbstract read
In one paragraph

Article in Cellular immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. [Pinostrobin targets the PI3K/AKT/CCLNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Turmeric andJournal of inflammation research · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

William F CarsonDepartment of Pathology, University of Michigan Medical School, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA. Electronic address: wfcarson@umich.edu.
Sarah E Salter-GreenDepartment of Pathology, University of Michigan Medical School, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA. Electronic address: sarahesgreen@gmail.com.
Melissa M ScolaDepartment of Pathology, University of Michigan Medical School, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA. Electronic address: scolam@umich.edu.
Amrita JoshiDepartment of Vascular Surgery, University of Michigan Medical School, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA. Electronic address: ajoshi@umich.edu.
Katherine A GallagherDepartment of Vascular Surgery, University of Michigan Medical School, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA. Electronic address: kgallag@umich.edu.
Steven L KunkelDepartment of Pathology, University of Michigan Medical School, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA. Electronic address: slkunkel@umich.edu.
University of Michigan · US

Funding

MONOKINE GENE EXPRESSION/REGULATION IN LUNG INJURYR01HL031237 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KUNKEL, STEVEN LYNN, STANDIFORD, THEODORE J. · 1985 to 2017
$5.9M
Cytokine-induced epigenetic changes during chronic lung diseaseR01HL112897 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DOU, YALI, KUNKEL, STEVEN LYNN · 2013 to 2016
$2.2M
Epigenetic Changes in Bone Marrow Progenitor Cells Impair Diabetic Wound HealingK08DK102357 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GALLAGHER, KATHERINE ANN · 2013 to 2017
$782k
The Immune Response to Pathogens is Controlled by the Cytokine-Induced Epigenetics SignatureR56AI129428 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KUNKEL, STEVEN LYNN · 2017 to 2017
$622k
NHLBI NIH HHS R01 HL031237NHLBI NIH HHS R01 HL112897NIAID NIH HHS R56 AI129428NIDDK NIH HHS K08 DK102357
6 · The paper itself

Abstract

Macrophage polarization plays a central role in both protective immunity and immunopathology. While the role of cytokines in driving macrophage polarization is well characterized, less is understood about the role of chemokines. The purpose of this study was to determine if CC chemokine 2 (CCL2/MCP1) could influence macrophage polarization in response to subsequent activation with cytokines and microbial products. Treatment of bone marrow-derived macrophages with CCL2 alone did not result in increased expression of either classical or alternatively-activated macrophage genes as compared to standard skewing cytokines or Toll-like receptor agonists. However, subsequent stimulation of CCL2 pre-treated macrophages with classical activation stimuli resulted in enhanced expression of genes associated with classical activation. This enhancement correlated with increased phosphorylation of ERK1/2 kinases, a decrease in expression of the ERK phosphatase Dusp6 and enhanced expression of miR-9. These results indicate that CCL2 supports the classical activation of macrophages, with miR-9 mediated down-regulation of Dusp6 and enhanced ERK-mediated signal transduction possibly mediating this enhanced pro-inflammatory gene expression.

Indexed as

Macrophage ActivationAnimalsCell DifferentiationCells, CulturedChemokine CCL2CytokinesDual Specificity Phosphatase 6FemaleGene Expression RegulationInflammationMacrophagesMAP Kinase Signaling SystemMiceMice, Inbred C57BLMicroRNAsTh1 CellsCcl2 protein, mouseChemokine CCL2CytokinesDual Specificity Phosphatase 6Dusp6 protein, mouseMicroRNAsMIRN9 microRNA, mouseToll-Like ReceptorsChemokinesGene regulationMacrophagesMicro-RNASignal transduction

Identifiers

PMID28242024
PMCPMC5425952
OpenAlexW2590285151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.